The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in income, its patent expiration created a wave of generic competition , significantly impacting its market share . While specific firms may attempt to capitalize on male sexual dysfunction, the existing